All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Occult HBV Infection-31516090

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	31516090	C124F	S	S	Occult HBV Infection	G C L	View
2	31516090	G130N	S	S	Occult HBV Infection	G C L	View
3	31516090	M133S	S	S	Occult HBV Infection	G C L	View
4	31516090	M133T	S	S	Occult HBV Infection	G C L	View
5	31516090	S132Y	S	S	Occult HBV Infection	G C L	View
6	31516090	T116N	S	S	Occult HBV Infection	G C L	View
7	31516090	T123N	S	S	Occult HBV Infection	G C L	View
8	31516090	T131N	S	S	Occult HBV Infection	G C L	View
9	31516090	C85R	S	S	Occult HBV Infection	G C L	View
10	31516090	C90R	S	S	Occult HBV Infection	G C L	View
11	31516090	L87R	S	S	Occult HBV Infection	G C L	View
12	31516090	L88R	S	S	Occult HBV Infection	G C L	View
13	31516090	Q16R	S	S	Occult HBV Infection	G C L	View
14	31516090	Q181R	S	S	Occult HBV Infection	G C L	View
15	31516090	W182R	S	S	Occult HBV Infection	G C L	View
16	31516090	N146D	S	S	Occult HBV Infection	G C L	View
17	31516090	N146S	S	S	Occult HBV Infection	G C L	View
18	31516090	N146Y	S	S	Occult HBV Infection	G C L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.